# Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure

> **NCT01028170** · PHASE3 · COMPLETED · sponsor: **Aspirus Heart and Vascular Institute-Research and Education** · enrollment: 50 (actual)

## Conditions studied

- Congestive Heart Failure
- Renal Insufficiency

## Interventions

- **DRUG:** furosemide and hypertonic saline solution
- **DRUG:** furosemide

## Key facts

- **NCT ID:** NCT01028170
- **Lead sponsor:** Aspirus Heart and Vascular Institute-Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-07
- **Final completion:** 2012-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028170, "Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01028170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*